GreenLight Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- GreenLight Biosciences's estimated annual revenue is currently $84.2M per year.
- GreenLight Biosciences received $Undisclosed in venture funding in January 2019.
- GreenLight Biosciences's estimated revenue per employee is $217,000
- GreenLight Biosciences's total funding is $340.5M.
- GreenLight Biosciences has 388 Employees.
- GreenLight Biosciences grew their employee count by 25% last year.
GreenLight Biosciences Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is GreenLight Biosciences?
GreenLight Biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented Cell free bioprocessing technology platform. This revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Solar Power,Wind Power
Number of Employees
Employee Growth %
GreenLight Biosciences News
GreenLight Biosciences Holdings has a market capitalization of US$1.1b, so we would expect some institutional investors to have noticed the...
GreenLight Biosciences makes affordable and accessible RNA products for human health and agriculture. · The company's cell-free RNA manufacturing...
GreenLight Biosciences Holdings PBC shares were up 15% to $10.50 after the company said it named Barney Graham to its Human Health...
GreenLight Biosciences announces business agreement with Environmental Impact Acquisition Corp. to become publicly traded company, allowing it to better harness its breakthrough platform to develop and produce RNA for human therapies and agriculture • GreenLight Biosciences, Inc. to become pub ...
GreenLight Biosciences, an ag biotech company using the RNA technology made famous by Covid-19 vaccines, has agreed to merge with a special purpose acquisition company (SPAC) in a deal that will value the company at $1.2 billion and list it on the Nasdaq [disclosure: AgFunder, AFN’s parent compa ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
GreenLight Biosciences Funding
|2015-07-23||$Undisclosed||C||MLS Capital Fund||Article|